Bionano Genomics, Inc.
BNGO
$3.27
$0.123.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.74% | 90.13% | 54.15% | 60.69% | 58.31% |
| Total Depreciation and Amortization | -20.01% | -18.74% | -32.85% | 54.52% | -9.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.56% | 17.70% | -46.72% | -70.48% | -166.77% |
| Change in Net Operating Assets | 82.50% | -61.83% | 136.23% | 11.04% | 30.45% |
| Cash from Operations | 83.38% | 90.17% | 78.16% | 49.38% | 42.83% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 84.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.11% | -129.54% | 105.49% | -116.04% | -4.28% |
| Cash from Investing | -93.09% | -129.56% | 105.41% | -116.08% | -3.20% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 88.30% | 99.96% | 77.65% | -25,025.00% | -214,866.67% |
| Issuance of Common Stock | -74.60% | -13.72% | -40.52% | -21.76% | -33.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 121.98% | -526.68% | 94.07% | -232.10% | -1,289.72% |
| Cash from Financing | 174.27% | 150.38% | -94.32% | -52.17% | -111.06% |
| Foreign Exchange rate Adjustments | -2,300.00% | 65.38% | -108.33% | 340.00% | 88.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.11% | -171.72% | 102.28% | -164.12% | -47.23% |